Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02402829 · ClinicalTrials.gov registry record

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture

A clinical trial, sponsored by Children's Mercy Hospital Kansas City.

Terminated
Registry status
3
Enrollment target

NCT02402829 is a clinical trial that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02402829 was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.

TERMINATED
Registry status
3 participants
Enrollment target

Study Summary

The purpose of this research study is to see if factor levels and inhibitor levels in Hemophilia A and B subjects are accurate when they are drawn from a central venous line (CVL) instead of from a peripheral stick.

Interventions

  • PROCEDURE Peripheral Vein Blood draw

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2014-11
Est. Completion 2018-11-28

What the Registry Record Tells You About NCT02402829

The ClinicalTrials.gov registry entry for NCT02402829 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Peripheral Vein Blood draw is the first listed.

NCT02402829 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02402829 about?

NCT02402829 is a clinical study titled "A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture". The purpose of this research study is to see if factor levels and inhibitor levels in Hemophilia A and B subjects are accurate when they are drawn from a central venous line (CVL) instead of from a peripheral stick.

What is the current status of trial NCT02402829?

This trial is currently terminated. The enrollment target is 3 participants. The study started on 2014-11. Estimated completion is 2018-11-28.

What interventions are being tested in trial NCT02402829?

The interventions under investigation include: Peripheral Vein Blood draw (PROCEDURE).

Who is sponsoring clinical trial NCT02402829?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.